Wellspring Financial Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$218K Buy
2,523
+33
+1% +$2.93K 0.01% 245
2026
Q2
$225K Buy
+2,490
New +$209K 0.01% 251
2022
Q2
– Sell
-1,699
Closed -$200K – 113
2022
Q1
$200K Hold
1,699
– – 0.06% 91
2021
Q4
$220K Buy
+1,699
New +$198K 0.06% 94

Other funds holding EW

Wellspring Financial Advisors's EW Position: Q3 2026 in Review

Wellspring Financial Advisors increased its Edwards Lifesciences (EW) stake by 1.3% in Q3 2026, buying an estimated $2.93K and bringing the position to 2,523 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #245.

Wellspring Financial Advisors first reported a position in EW in Q4 2021 and has held it in 4 quarters since. The position peaked at $225K in Q2 2026. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Wellspring Financial Advisors held 2,523 shares of Edwards Lifesciences worth $218K as of Q3 2026.
  • Wellspring Financial Advisors bought 33 Edwards Lifesciences shares in Q3 2026, an estimated $2.93K.
  • Edwards Lifesciences made up 0.01% of Wellspring Financial Advisors's portfolio in Q3 2026, its #245 holding.
  • Wellspring Financial Advisors first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 4 quarters since.
  • Wellspring Financial Advisors's Edwards Lifesciences position peaked at $225K in Q2 2026.
  • 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Wellspring Financial Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.